HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AME 133

an anti-CD20 antibody for treatment of cancer in phase I/II clinical trials (2010)
Also Known As:
AME-133; AME133; LY 2469298; LY-2469298; LY2469298
Networked: 2 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wooldridge, James E: 2 articles (03/2012 - 02/2011)
2. Cronier, Damien M: 1 article (03/2012)
3. Pohlman, Brad L: 1 article (03/2012)
4. Nelson, James G: 1 article (03/2012)
5. de Vos, Sven: 1 article (03/2012)
6. Smith, Mitchell R: 1 article (03/2012)
7. Slapak, Christopher A: 1 article (03/2012)
8. Dang, Nam H: 1 article (03/2012)
9. Carpenter, Susan P: 1 article (03/2012)
10. Link, Brian K: 1 article (03/2012)

Related Diseases

1. Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)